Literature DB >> 32402520

Safety and efficacy of transcatheter closure of outlet-type ventricular septal defects in children and adults with Amplatzer Duct Occluder II.

Hsin-Chia Lin1, Ming-Tai Lin2, Chun-An Chen2, Jui-Yu Hsu3, Su-Man Lin4, Mei-Hwan Wu2, Jou-Kou Wang5.   

Abstract

BACKGROUND/
PURPOSE: Outlet-type VSD is frequently associated with aortic valve prolapse that surgery is frequently required. The literature regarding outcomes of transcatheter closure of outlet-type VSDs is scant. This study was conducted to know the safety and efficacy of transcatheter closure of outlet-type ventricular septal defects (VSDs) with Amplatzer Duct Occluder II (ADO II).
METHODS: Medical records of patients underwent attempted transcatheter closure of outlet-type VSD with ADO II between October 2013 and August 2019 were retrospectively reviewed.
RESULTS: Among 49 patients, transcatheter closure was successful in 45 (91.8%; 33 males and 12 females; mean [± standard deviation] age and body weight: 15.8 (±17.7) years and 36.6 (±23.3) kg, respectively). The median VSD diameter was 4.0 mm (range: 1.2-6.0 mm). Device closure failed in four because the sheath could not be advanced through a prograde or retrograde route in one patient, occluder embolization in the two patients, and failed right ventricular disc anchoring in one patient. After a mean follow-up of 22.7 months (range: 0.3-51.1 months), only nine (20.0%) patients had increased severity in aortic regurgitation (AR) on the echocardiography. Preprocedural AR decreased in severity or even disappeared in 11 (24.4%) patients. No heart block or device failure occurred during follow-up. A trivial-to-small residual shunt was detected in 19 patients (42.2%) in the most recent echocardiography.
CONCLUSION: Transcatheter closure of outlet-type VSDs with ADO II is feasible. Although no significant aggravation of AR was observed in the short-to-mid-term follow-up, long-term follow-up is mandatory.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Amplatzer Duct Occluder II; Aortic regurgitation; Ventricular septal defect

Mesh:

Year:  2020        PMID: 32402520     DOI: 10.1016/j.jfma.2020.04.015

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  5 in total

1.  Safety and Efficacy of Transcatheter Occlusion of Perimembranous Ventricular Septal Defect with Aortic Valve Prolapse: A Six-Year Follow-Up Study.

Authors:  Wenqian Zhang; Chaojie Wang; Shenrong Liu; Lingmei Zhou; Junjie Li; Jijun Shi; Mingyang Qian; Shushui Wang; Yu-Mei Xie; Zhiwei Zhang
Journal:  J Interv Cardiol       Date:  2021-03-18       Impact factor: 2.279

2.  Transcatheter Closure of Perimembranous and Intracristal Ventricular Septal Defects Using Amplatzer Duct Occluder II in Children.

Authors:  Shenrong Liu; Wenqian Zhang; Junjie Li; Shushui Wang; Mingyang Qian; Jijun Shi; Yumei Xie; Zhiwei Zhang
Journal:  J Interv Cardiol       Date:  2021-09-11       Impact factor: 2.279

3.  Echocardiographic Classification and Guidance for Transcatheter Closure of Ventricular Septal Defect.

Authors:  So-Ick Jang; Seong Ho Kim
Journal:  J Cardiovasc Imaging       Date:  2021-10

4.  Transfemoral Occlusion of Doubly Committed Subarterial Ventricular Septal Defect Using the Amplatzer Duct Occluder-II in Children.

Authors:  Changqing Tang; Kaiyu Zhou; Shuran Shao; Xiaoliang Liu; Yifei Li; Yimin Hua; Chuan Wang
Journal:  Front Cardiovasc Med       Date:  2022-04-12

5.  The Long-Term Change of Arrhythmias after Transcatheter Closure of Perimembranous Ventricular Septal Defects.

Authors:  Hongyan Zheng; Aiwen Lin; Li Wang; Yukai Xu; Zhiwei Zhang
Journal:  Cardiol Res Pract       Date:  2021-06-22       Impact factor: 1.866

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.